Rebecca Kruse-Jarres

Summary

Affiliation: Tulane University
Country: USA

Publications

  1. doi request reprint Inhibitors: our greatest challenge. Can we minimize the incidence?
    R Kruse-Jarres
    School of Medicine Section of Hematology Oncology, Tulane University, New Orleans, LA, USA
    Haemophilia 19:2-7. 2013
  2. doi request reprint Management of bleeding disorders in the elderly
    R Kruse-Jarres
    Tulane University School of Medicine, New Orleans, LA 70112, USA
    Haemophilia 18:37-45. 2012
  3. doi request reprint Current controversies in the formation and treatment of alloantibodies to factor VIII in congenital hemophilia A
    Rebecca Kruse-Jarres
    Tulane University School of Medicine, New Orleans, LA 70112, USA
    Hematology Am Soc Hematol Educ Program 2011:407-12. 2011
  4. doi request reprint Current management of acquired factor VIII inhibitors
    Brian Barnett
    Tulane University School of Medicine, New Orleans, Louisiana, USA
    Curr Opin Hematol 15:451-5. 2008
  5. doi request reprint Emergency department care for patients with hemophilia and von Willebrand disease
    Tammuella Singleton
    Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA
    J Emerg Med 39:158-65. 2010
  6. ncbi request reprint Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A
    Rebecca Kruse-Jarres
    Louisiana Center for Bleeding and Clotting Disorders TB 31, 1430 Tulane Avenue, New Orleans, Louisiana 70221 2699, USA
    Expert Opin Biol Ther 8:1885-96. 2008
  7. doi request reprint Reduced production of IFN-γ and LT-α is associated with successful prednisone therapy in patients with acquired hemophilia A: a pilot study
    Rebecca Kruse-Jarres
    Tulane University Health Sciences Center, Tulane School of Medicine, Section of Hematology Oncology, Louisiana Comprehensive Hemophilia Care Center, New Orleans, LA 70112 2699, USA
    Thromb Res 128:e86-90. 2011
  8. doi request reprint Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state
    Tiffany R Chang
    1Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, LA, USA
    Clin Appl Thromb Hemost 20:124-8. 2014

Collaborators

  • W Schramm
  • G Dolan
  • Tiffany R Chang
  • Cindy Leissinger
  • Tammuella Singleton
  • Brian Barnett
  • E Alton Sartor
  • Sheryl Martin-Schild
  • Amelia K Boehme
  • Adrianne Dorsey
  • Karen C Albright
  • Cindy A Leissinger

Detail Information

Publications8

  1. doi request reprint Inhibitors: our greatest challenge. Can we minimize the incidence?
    R Kruse-Jarres
    School of Medicine Section of Hematology Oncology, Tulane University, New Orleans, LA, USA
    Haemophilia 19:2-7. 2013
    ....
  2. doi request reprint Management of bleeding disorders in the elderly
    R Kruse-Jarres
    Tulane University School of Medicine, New Orleans, LA 70112, USA
    Haemophilia 18:37-45. 2012
    ....
  3. doi request reprint Current controversies in the formation and treatment of alloantibodies to factor VIII in congenital hemophilia A
    Rebecca Kruse-Jarres
    Tulane University School of Medicine, New Orleans, LA 70112, USA
    Hematology Am Soc Hematol Educ Program 2011:407-12. 2011
    ....
  4. doi request reprint Current management of acquired factor VIII inhibitors
    Brian Barnett
    Tulane University School of Medicine, New Orleans, Louisiana, USA
    Curr Opin Hematol 15:451-5. 2008
    ..Appropriate management requires the urgent treatment of bleeding episodes and prompt institution of immunosuppressive therapy for long-term inhibitor eradication...
  5. doi request reprint Emergency department care for patients with hemophilia and von Willebrand disease
    Tammuella Singleton
    Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA
    J Emerg Med 39:158-65. 2010
    ..The aim of this review is to outline some of the issues facing emergency physicians and the options available for the treatment of patients with hemophilia A, hemophilia B, and VWD...
  6. ncbi request reprint Immune tolerance induction for the eradication of inhibitors in patients with hemophilia A
    Rebecca Kruse-Jarres
    Louisiana Center for Bleeding and Clotting Disorders TB 31, 1430 Tulane Avenue, New Orleans, Louisiana 70221 2699, USA
    Expert Opin Biol Ther 8:1885-96. 2008
    ..Immune tolerance induction (ITI) is usually attempted to eradicate newly diagnosed inhibitors, restore replacement FVIII pharmacokinetics, and improve bleed management and quality of life...
  7. doi request reprint Reduced production of IFN-γ and LT-α is associated with successful prednisone therapy in patients with acquired hemophilia A: a pilot study
    Rebecca Kruse-Jarres
    Tulane University Health Sciences Center, Tulane School of Medicine, Section of Hematology Oncology, Louisiana Comprehensive Hemophilia Care Center, New Orleans, LA 70112 2699, USA
    Thromb Res 128:e86-90. 2011
    ..This study suggests that the secretion level of IFN-γ and/or LT-α could be a predictive marker of prednisone responsiveness...
  8. doi request reprint Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state
    Tiffany R Chang
    1Stroke Program, Department of Neurology, Tulane University School of Medicine, New Orleans, LA, USA
    Clin Appl Thromb Hemost 20:124-8. 2014
    ..Elevation of factor VIII is associated with higher risk of large vessel arterial occlusions including stroke...